BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20931248)

  • 1. Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.
    Moreira EL; Rial D; Aguiar AS; Figueiredo CP; Siqueira JM; DalBó S; Horst H; de Oliveira J; Mancini G; dos Santos TS; Villarinho JG; Pinheiro FV; Marino-Neto J; Ferreira J; De Bem AF; Latini A; Pizzolatti MG; Ribeiro-do-Valle RM; Prediger RD
    J Neural Transm (Vienna); 2010 Dec; 117(12):1337-51. PubMed ID: 20931248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
    Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
    Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Matheus FC; Aguiar AS; Castro AA; Villarinho JG; Ferreira J; Figueiredo CP; Walz R; Santos AR; Tasca CI; Prediger RD
    Behav Brain Res; 2012 Dec; 235(2):263-72. PubMed ID: 22921927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of the proanthocyanidin-rich fraction in experimental model of spinal cord injury.
    Assis LC; Hort MA; de Souza GV; Martini AC; Forner S; Martins DF; Silva JC; Horst H; dos Santos AR; Pizzolatti MG; Rae GA; Koepp J; de Bem AF; do Valle RM
    J Pharm Pharmacol; 2014 May; 66(5):694-704. PubMed ID: 24438047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
    Castro AA; Wiemes BP; Matheus FC; Lapa FR; Viola GG; Santos AR; Tasca CI; Prediger RD
    Brain Res; 2013 Jun; 1513():103-16. PubMed ID: 23548600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats.
    Moreira EL; Rial D; Duarte FS; de Carvalho CR; Horst H; Pizzolatti MG; Prediger RD; Ribeiro-do-Valle RM
    J Pharm Pharmacol; 2010 Aug; 62(8):1061-8. PubMed ID: 20663041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: focus on atherosclerosis.
    Hort MA; Straliotto MR; Duz MS; Netto PM; Souza CB; Schulz T; Horst H; Pizzolatti MG; de Bem AF; Ribeiro-do-Valle RM
    Food Chem Toxicol; 2012 Oct; 50(10):3769-75. PubMed ID: 22884763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the vasorelaxant effect induced by proanthocyanidin-rich fraction from Croton celtidifolius in rat small resistance arteries.
    DalBó S; Moreira EG; Brandão FC; Horst H; Pizzolatti MG; Micke GA; Ribeiro-do-Valle RM
    J Pharmacol Sci; 2008 Feb; 106(2):234-41. PubMed ID: 18296862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
    Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
    Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of endothelial nitric oxide synthase by proanthocyanidin-rich fraction from Croton celtidifolius (Euphorbiaceae): involvement of extracellular calcium influx in rat thoracic aorta.
    DalBó S; Goulart S; Horst H; Pizzolatti MG; Ribeiro-do-Valle RM
    J Pharmacol Sci; 2008 Jun; 107(2):181-9. PubMed ID: 18566521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.
    Prediger RD; Aguiar AS; Rojas-Mayorquin AE; Figueiredo CP; Matheus FC; Ginestet L; Chevarin C; Bel ED; Mongeau R; Hamon M; Lanfumey L; Raisman-Vozari R
    Neurotox Res; 2010 Feb; 17(2):114-29. PubMed ID: 19629612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease.
    Prediger RD; Rial D; Medeiros R; Figueiredo CP; Doty RL; Takahashi RN
    Ann N Y Acad Sci; 2009 Jul; 1170():629-36. PubMed ID: 19686204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
    Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
    Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purple pitanga extract (Eugenia uniflora) attenuates oxidative stress induced by MPTP.
    Fidelis EM; Savall ASP; Mello JD; Quines CB; Comis-Neto AA; Sampaio TB; Denardin CC; de Ávila DS; Rosa SG; Pinton S
    Metab Brain Dis; 2023 Dec; 38(8):2615-2625. PubMed ID: 37921949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
    Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
    Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effect of Croton celtidifolius Baill (Euphorbiaceae).
    Nardi GM; Dalbó S; Monache FD; Pizzolatti MG; Ribeiro-do-Valle RM
    J Ethnopharmacol; 2006 Aug; 107(1):73-8. PubMed ID: 16564657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.